The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
The discovery of vaccine antigens through whole genome sequencing (WGS) contrasts with the classical hypothesis-driven laboratory-based analysis of microbes to identify components to elicit protective immunity. This radical change in scientific direction and action in vaccine research is captured in...
Main Authors: | Vega Masignani, Mariagrazia Pizza, E. Richard Moxon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00751/full |
Similar Items
-
Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
by: George Kassianos, et al.
Published: (2023-07-01) -
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland
by: Robert M. Mulhall, et al.
Published: (2018-08-01) -
Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017-05-01) -
Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines
by: Alessandro Muzzi, et al.
Published: (2022-10-01) -
Meningococcal B vaccine (4CMenB): the journey from research to real world experience
by: Rino Rappuoli, et al.
Published: (2018-12-01)